GENÉTICA MOLECULAR EN ONCOHEMATOLOGÍA
Consejo Superior de Investigaciones Científicas
Madrid, EspañaPublications en collaboration avec des chercheurs de Consejo Superior de Investigaciones Científicas (7)
2022
-
CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
Molecular Dissection of Structural Variations Involved in Antithrombin Deficiency
Journal of Molecular Diagnostics, Vol. 24, Núm. 5, pp. 462-475
2021
-
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
Leukemia Research, Vol. 109
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients
Annals of Hematology, Vol. 100, Núm. 8, pp. 1995-2004
2019
-
1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia
Clinical and Experimental Medicine, Vol. 19, Núm. 2, pp. 261-267
2017
-
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
Oncotarget, Vol. 8, Núm. 16, pp. 26027-26040